Brian Elsbernd Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity

Brian Elsbernd is Chief Compliance/Legal Officer of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 242,501 shares of CPRX, which is worth approximately $5.62 Million. The most recent transaction as insider was on Dec 29, 2025, when has been sold 2,623 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 243K

10.53% 3M change

33.79% 12M change

Total Value Held $5.62 Million

Brian Elsbernd Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 29 2025	SELL Payment of exercise price or tax liability	-	2,623 Reduced 1.07%	242,501 Common Stock, par valu...
Dec 29 2025	BUY Exercise of conversion of derivative security	-	6,667 Added 2.65%	245,124 Common Stock, par valu...
Dec 08 2025	SELL Payment of exercise price or tax liability	-	2,780 Reduced 1.15%	238,457 Common Stock, par valu...
Dec 08 2025	BUY Exercise of conversion of derivative security	-	7,067 Added 2.85%	241,237 Common Stock, par valu...
Nov 21 2025	SELL Payment of exercise price or tax liability	-	2,030 Reduced 0.86%	234,170 Common Stock, par valu...
Nov 21 2025	BUY Exercise of conversion of derivative security	-	5,161 Added 2.14%	236,200 Common Stock, par valu...
Nov 12 2025	BUY Open market or private sale	$908,000 $22.7 p/Share	40,000 Added 14.76%	231,039 Common Stock, par valu...

Sep 08 2025	SELL Open market or private sale	$609,000 $20.3 p/Share	30,000 Reduced 9.97%	271,039 Common Stock, par valu...
Sep 08 2025	BUY Exercise of conversion of derivative security	$251,944 $2.24 p/Share	112,475 Added 27.2%	301,039 Common Stock, par valu...
Sep 04 2025	SELL Open market or private sale	$585,600 $19.52 p/Share	30,000 Reduced 13.73%	188,564 Common Stock, par valu...
Sep 04 2025	BUY Exercise of conversion of derivative security	$67,200 $2.24 p/Share	30,000 Added 12.07%	218,564 Common Stock, par valu...
Sep 03 2025	SELL Open market or private sale	$401,599 $20.08 p/Share	20,000 Reduced 9.59%	188,564 Common Stock, par valu...
Sep 03 2025	BUY Exercise of conversion of derivative security	$44,800 $2.24 p/Share	20,000 Added 8.75%	208,564 Common Stock, par valu...
Mar 03 2025	SELL Open market or private sale	$1,453,463 $23.08 p/Share	62,975 Reduced 25.04%	188,564 Common Stock, par valu...
Mar 03 2025	BUY Exercise of conversion of derivative security	$140,056 $2.24 p/Share	62,525 Added 20.54%	241,819 Common Stock, par valu...
Feb 14 2025	SELL Payment of exercise price or tax liability	-	2,353 Reduced 1.23%	188,564 Common Stock, par valu...
Feb 14 2025	BUY Exercise of conversion of derivative security	-	9,667 Added 4.82%	190,917 Common Stock, par valu...
Dec 27 2024	SELL Payment of exercise price or tax liability	-	1,941 Reduced 1.06%	181,250 Common Stock, par valu...
Dec 27 2024	BUY Exercise of conversion of derivative security	-	6,667 Added 3.51%	183,191 Common Stock, par valu...
Dec 09 2024	SELL Payment of exercise price or tax liability	-	1,720 Reduced 0.96%	176,524 Common Stock, par valu...
Dec 09 2024	BUY Exercise of conversion of derivative security	-	7,067 Added 3.81%	178,244 Common Stock, par valu...
Nov 26 2024	SELL Open market or private sale	$286,594 $21.62 p/Share	13,256 Reduced 7.19%	171,177 Common Stock, par valu...
Nov 26 2024	BUY Exercise of conversion of derivative security	$240,600 $4.01 p/Share	60,000 Added 25.52%	175,133 Common Stock, par valu...
Mar 27 2024	SELL Open market or private sale	$411,000 $16.44 p/Share	25,000 Reduced 16.73%	124,433 Common Stock, par valu...
Feb 15 2024	SELL Payment of exercise price or tax liability	-	2,353 Reduced 1.55%	149,433 Common Stock, par valu...

Brian Elsbernd

Chief Compliance/Legal Officer

Coral Gables, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CPRX shares.

Notify only if

Value

Insider Trading

Get notified when an Catalyst Pharmaceuticals, Inc. insider buys or sells CPRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to CATALYST PHARMACEUTICALS, INC.

Track Activities on CPRX

Account